ArticleNature cancer2021

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy.

Jason I Griffiths et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.